February 5 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Tuesday that its sales edged up 1% year-on-year in January.
Sopharma's exports grew 13% on the year in January, while domestic sales decreased 15% on the year, the drug maker said in a bourse filing.
The company did not disclose information about the volume of its sales or amount of sales revenue.
As at 12:45 CET on Tuesday, Sopharma shares traded at 3.5 levs ($2.04/1.79 euro), unchanged from their previous closing price on the Bulgarian Stock Exchange.
Sopharma has 10 production facilities with a portfolio of over 210 products.
(1 euro = 1.95583 levs)